NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis $1.80 +0.13 (+7.78%) Closing price 04:00 PM EasternExtended Trading$1.75 -0.05 (-3.00%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Cardlytics Stock (NASDAQ:CDLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cardlytics alerts:Sign Up Key Stats Today's Range$1.65▼$1.8550-Day Range$1.44▼$2.1752-Week Range$1.22▼$9.48Volume925,786 shsAverage Volume999,049 shsMarket Capitalization$94.50 millionP/E RatioN/ADividend YieldN/APrice Target$3.50Consensus RatingHold Company Overview Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Read More Cardlytics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks80th Percentile Overall ScoreCDLX MarketRank™: Cardlytics scored higher than 80% of companies evaluated by MarketBeat, and ranked 68th out of 316 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.Amount of Analyst CoverageCardlytics has only been the subject of 1 research reports in the past 90 days.Read more about Cardlytics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cardlytics' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted15.98% of the float of Cardlytics has been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in Cardlytics has recently decreased by 6.42%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Sustainability and ESG2.8 / 5Environmental Score-0.67 Percentage of Shares Shorted15.98% of the float of Cardlytics has been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in Cardlytics has recently decreased by 6.42%, indicating that investor sentiment is improving significantly. News and Social Media3.9 / 5News Sentiment1.07 News SentimentCardlytics has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Cardlytics this week, compared to 5 articles on an average week.Search Interest5 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows2 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,847.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cardlytics' insider trading history. Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDLX Stock News HeadlinesAnalysts Set Cardlytics, Inc. (NASDAQ:CDLX) PT at $3.50July 2 at 2:15 AM | americanbankingnews.comCardlytics: Underrecognized Margin Recovery; Strong Buy ReiteratedMay 26, 2025 | seekingalpha.comTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...July 2 at 2:00 AM | InvestorPlace (Ad)Cardlytics Launches Cardlytics Rewards Platform and Expands Publisher Base Beyond Financial InstitutionsMay 21, 2025 | finance.yahoo.comCardlytics, Inc. (NASDAQ:CDLX) Just Reported, And Analysts Assigned A US$2.54 Price TargetMay 10, 2025 | finance.yahoo.comEarnings call transcript: Cardlytics Q1 2025 beats EPS forecast, stock risesMay 9, 2025 | investing.comCardlytics, Inc. (CDLX) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comCardlytics Announces First Quarter 2025 Financial ResultsMay 7, 2025 | businesswire.comSee More Headlines CDLX Stock Analysis - Frequently Asked Questions How have CDLX shares performed this year? Cardlytics' stock was trading at $3.71 at the start of the year. Since then, CDLX shares have decreased by 51.5% and is now trading at $1.80. View the best growth stocks for 2025 here. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) announced its quarterly earnings results on Wednesday, November, 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.33) by $0.18. The company's quarterly revenue was down 15.1% on a year-over-year basis. Read the conference call transcript. Does Cardlytics have any subsidiaries? The following companies are subsidiaries of Cardlytics: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited. When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS). Company Calendar Last Earnings11/06/2024Today7/02/2025Next Earnings (Estimated)7/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Technology Services Sub-IndustryComputer Software Current SymbolNASDAQ:CDLX CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees500Year Founded2008Price Target and Rating Average Stock Price Target$3.50 High Stock Price Target$5.00 Low Stock Price Target$2.50 Potential Upside/Downside+94.4%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($3.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$189.30 million Net Margins-65.41% Pretax Margin-65.41% Return on Equity-172.36% Return on Assets-42.07% Debt Debt-to-Equity Ratio2.62 Current Ratio1.19 Quick Ratio1.19 Sales & Book Value Annual Sales$278.30 million Price / Sales0.34 Cash FlowN/A Price / Cash FlowN/A Book Value$1.38 per share Price / Book1.30Miscellaneous Outstanding Shares52,500,000Free Float50,192,000Market Cap$94.50 million OptionableOptionable Beta1.21 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:CDLX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardlytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.